-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Nh3NaqX1Wo587kTPUOwQLkC77G6yED7be4ZZO+aefjgiPbzDMHzzpBrVq5Wk8m9V
 h8lhTC3bKgP0WEZ5xhRrmg==

<SEC-DOCUMENT>0001019687-04-002359.txt : 20041029
<SEC-HEADER>0001019687-04-002359.hdr.sgml : 20041029
<ACCEPTANCE-DATETIME>20041029161802
ACCESSION NUMBER:		0001019687-04-002359
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041025
FILED AS OF DATE:		20041029
DATE AS OF CHANGE:		20041029

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Waltz Thomas A
		CENTRAL INDEX KEY:			0001307421

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17085
		FILM NUMBER:		041106679

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		714-508-6047

	MAIL ADDRESS:	
		STREET 1:		14272 FRANKLIN AVENUE, #100
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PEREGRINE PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000704562
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				953698422
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	BUSINESS ADDRESS:	
		STREET 1:		14282 FRANKLIN AVE
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780
		BUSINESS PHONE:		7145086000

	MAIL ADDRESS:	
		STREET 1:		14282 FRANKLIN AVE
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECHNICLONE CORP/DE/
		DATE OF NAME CHANGE:	19970924

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECHNICLONE INTERNATIONAL CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2004-10-25</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000704562</issuerCik>
        <issuerName>PEREGRINE PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>PPHM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001307421</rptOwnerCik>
            <rptOwnerName>Waltz Thomas A</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PEREGRINE PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>14272 FRANKLIN AVENUE, SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>TUSTIN,</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92780</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.15</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2014-10-26</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>300000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value></value>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Option vests one-third on the date of grant, one-third on October 26, 2005, and one-third on October 26, 2006.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>Thomas A. Waltz</signatureName>
        <signatureDate>2004-10-27</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----